Mi-Ae Lyu

机构：The University of Texas MD Anderson Cancer Center

发表论文 42 篇 · 总被引 186 次 · h-index 8

代表论文

• Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS (2023 · Blood Advances · 被引 36)
• Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALS (2025 · NEJM Evidence · 被引 17)
• Allogeneic cord blood regulatory T cells can resolve lung inflammation (2022 · Cytotherapy · 被引 17)
• Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus (2023 · Frontiers in Immunology · 被引 16)
• Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes (2024 · NEJM Evidence · 被引 13)
• CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation (2024 · iScience · 被引 11)